What does NanJing Pharmaceutical Company Limited do?

NanJing Pharmaceutical Company Limited (600713.SS) operates in the Medical - Distribution industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 600713.SS's market cap?

NanJing Pharmaceutical Company Limited (600713.SS) has a market capitalization of approximately $6.88 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 600713.SS pay a dividend?

Yes — NanJing Pharmaceutical Company Limited (600713.SS) pays a dividend annually, with a trailing-twelve-month yield of 3.23%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

600713.SS

NanJing Pharmaceutical Company Limited

SHH·Medical, Distribution · Healthcare

¥5.26¥0.01+0.19%

Market cap¥6.88B·Aug 26 7:00 AM UTC

Price Chart

¥5.26+¥0.01 (+0.19%)today

+19.27%CAGR +3.59%

Select date range

FromTo

Jul 1, 1996Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)3.23%

Annual Dividend (FWD)¥0.17

Dividend Growth (5Y)+9.1%

Dividend Safety—

Payout Ratio40.4%

FCF Payout Ratio—

Most Recent Dividend¥0.170

Ex-Dividend DateJun 30

Payment DateJun 30

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)−8.2%

EPS Growth (3Y)−4.1%

EPS Growth (5Y)+1.9%

Next Earnings DateMay 30

Last Report DateMay 30

Reported vs Estimate¥0.09

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥54.56B

Net Income¥622.04M

Net Margin1.1%

Operating Cash Flow−¥1.50B

Capital Expenditures¥252.96M

Free Cash Flow−¥1.75B

Return on Equity8.5%

Return on Invested Capital1.2%

Net Debt¥7.04B

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 600713.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 600713.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 600713.SS and 80,000+ other tickers.

About NanJing Pharmaceutical Company Limited

Established in 1951 and headquartered in Nanjing, China, NanJing Pharmaceutical Company Limited specializes in the nationwide wholesale and retail distribution of pharmaceutical products. The company oversees a substantial network comprising approximately 510 physical pharmacy outlets, alongside an active e-commerce platform for online sales.

CEO: Liang Zhang
Sector: Healthcare
Industry: Medical - Distribution
Exchange: SHH
Employees: 4,697
Website: www.njyy.com

Peers

Peers Tab

000411.SZ

Zhejiang Int'l Group Co.,Ltd.

Cap

¥5.5B

000908.SZ

Hunan Jingfeng Pharmaceutical Co.,Ltd.

Cap

¥11.5B

300039.SZ

Shanghai Kaibao Pharmaceutical CO.,Ltd

Cap

¥6.0B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 600713.SS

What does NanJing Pharmaceutical Company Limited do?: NanJing Pharmaceutical Company Limited (600713.SS) operates in the Medical - Distribution industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 600713.SS's market cap?: NanJing Pharmaceutical Company Limited (600713.SS) has a market capitalization of approximately $6.88 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 600713.SS pay a dividend?: Yes — NanJing Pharmaceutical Company Limited (600713.SS) pays a dividend annually, with a trailing-twelve-month yield of 3.23%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.